<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Type 2 diabetic patients are characterized by a reduced <z:chebi fb="3" ids="16335">adenosine</z:chebi>-induced hyperemic myocardial perfusion, which may contribute to their increased <z:e sem="disease" ids="C1301700" disease_type="Disease or Syndrome" abbrv="">cardiovascular morbidity</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We hypothesized that the reduced hyperemia can be explained by functional changes in endothelial or autonomic <z:mp ids='MP_0008912'>nervous</z:mp> regulation </plain></SENT>
<SENT sid="2" pm="."><plain>In 12 type 2 diabetic patients without signs of <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> and 14 age-matched control subjects, myocardial perfusion was measured at rest, during <z:chebi fb="3" ids="16335">adenosine</z:chebi>, and during <z:chebi fb="3" ids="16335">adenosine</z:chebi> and alpha-receptor blockade (phentolamine) using <z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography on two separate days: 1) with, and 2) without nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO) inhibition with N(G)-<z:chebi fb="13" ids="29785">nitro</z:chebi>-<z:chebi fb="0" ids="16467,29952">L-arginine</z:chebi> <z:chebi fb="36" ids="29309">methyl</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Myocardial perfusion during <z:chebi fb="3" ids="16335">adenosine</z:chebi> was lower in type 2 diabetic patients compared with control subjects (P = 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>No significant effect of NO inhibition on myocardial perfusion during <z:chebi fb="3" ids="16335">adenosine</z:chebi> was found in any of the groups </plain></SENT>
<SENT sid="5" pm="."><plain>In control subjects, alpha-receptor blockade increased hyperemic myocardial vascular resistance during NO inhibition, whereas no effect was observed in type 2 diabetic patients </plain></SENT>
<SENT sid="6" pm="."><plain>At rest, a significant correlation was observed between rate-pressure product and myocardial perfusion in control subjects </plain></SENT>
<SENT sid="7" pm="."><plain>NO inhibition and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> abolished this correlation </plain></SENT>
<SENT sid="8" pm="."><plain>Endothelial and cardiac autonomic nerve function seems to play only a minimal role in the reduced hyperemic myocardial perfusion in type 2 diabetic patients </plain></SENT>
<SENT sid="9" pm="."><plain>However, the linear correlation between resting perfusion and cardiac work appears to be abolished in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and during NO synthase inhibition </plain></SENT>
</text></document>